About Us
At PreciOnc, a dedicated initiative by BioServe India, we are committed to transforming cancer diagnostics and prevention through advanced genetic testing. Our goal is to provide individuals and healthcare providers with accurate, personalized insights into hereditary cancer risks, enabling early detection and better treatment outcomes.
Leveraging cutting-edge technology and years of expertise in clinical diagnostics, we focus on precision oncology, offering a comprehensive suite of genetic tests that help identify and manage cancer predisposition. Our services empower patients to make informed decisions, guiding them towards preventive strategies and personalized care plans.
With a commitment to innovation, accessibility, and patient well-being, PreciOnc ensures that our testing process is seamless, non-invasive, and available from the comfort of your home. Our dedicated team of genetic experts, clinicians, and researchers is here to support you every step of the way, ensuring that you receive the best care and the most accurate results.
WHO WE ARE
PreciOnc, part of BioServe India, is a leader in clinical diagnostics specializing in early cancer detection through advanced genetic testing. With over 20 years of expertise, we deliver high-quality services across the nation. Our core competencies extend to oligosynthesis and molecular services, establishing us as a trusted name in the industry.
Now part of the global Reprocell Group, a JASDAQ-listed company headquartered in Japan, our capabilities have grown significantly. We offer a diverse range of services, including nucleic acid processing, sequencing, gene expression analysis, and genotyping, enabling us to better serve our clients both in India and around the world.
Our Vision
To revolutionize cancer diagnostics by providing personalized, precision-driven genetic insights that empower individuals to take control of their health and future, and to be at the forefront of innovation in hereditary cancer testing.
Our Mission
At Precion.com, our mission is to enhance early detection and prevention of cancer through advanced genetic testing. We aim to provide accurate, accessible, and personalized diagnostic services that enable healthcare professionals and patients to make informed decisions, ultimately improving treatment outcomes and saving lives.
